during the promptly evolving field of cancer therapeutics, knowing the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is very important for building productive treatment plans. One of the more promising approaches is using in vitro bystander effect assays, which Participate in a pivotal function in enhancing therapeutic efficacy. These ass